BioSpace News Archive

New data further reinforce Ocrevus (ocrelizumab) as a highly effective treatment option offering a favorable and consistent benefit:risk profile, with high treatment persistence and adherence

Oncology makes for a field that is consistently evolving owing to great amount of research and development activities are currently underway to formulate therapies and drugs to treat tumors that cause cancer as well as emerge as a result of chemotherapies.

New technologies are emerging within the separation systems relating to chromatographic devices and consumables biotechnology. This is attracting many new players in the market.

Burning Rock Biotech Limited announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference.

BreviTest Technologies announced that the FDA has officially accepted BreviTest’s official notification of its intent to commercially distribute its IgG antibody test under policy outlined in Section IV.D. of the Policy for Coronavirus Diseases - 2019 Tests.

BEDFORD, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care, today announced that Cheryl R. Blanchard, Ph.D., President and Chief Executive Officer, and Michael Levitz, Chief Financial Officer, will participate in the following four virtual investor conferences in September: Barrington Research Fa

Problems with failing memory are common for many individuals as they grow older, and is particularly characteristic of patients with Alzheimer’s disease. Research shows that aging-related cognitive decline may be affected by Omega-3 levels and the health of cell membranes. Certain nutritional supplements developed to target

Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, Sept. 9. A webcast of the event will be available for the investment community. The details: What: Wells Fargo 2020 Virtual Healthcare Conference When: Wednesday, Sept. 9 at 10:40 a.m. (EDT) Who: Bob McMahon, Agilent chief financial officer Wh

Organovo Holdings, Inc. (“Organovo” or the “Company”) (Nasdaq: ONVO) announced today that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market (the “ Minimum Bid Price Requirement ”). On September 2, 2020, Organovo received a letter from the Listing Qualifications Department of The Nasdaq Stock Market, Inc. stating that because Organovo’s common stock had a closing bid price at or a

Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that its management team will participate in the Cantor Fitzgerald Virtual Global Healthcare Conference which takes place September 15-17, 2020. Ron Rocca, President and CEO of Exagen, will engage in a fireside chat on September 15 at 2:40 pm EDT. A link to the live webcast of Mr. Rocca’s firesi